|
|
Volumn 27, Issue 11, 2009, Pages 966-967
|
|
Genzyme backs Osiris, despite Prochymal flop
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ORPHAN DRUG;
PLACEBO;
PROCHYMAL;
UNCLASSIFIED DRUG;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
CROHN DISEASE;
FOOD AND DRUG ADMINISTRATION;
GRAFT VERSUS HOST REACTION;
HEART INFARCTION;
HUMAN;
MESENCHYMAL STEM CELL TRANSPLANTATION;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
ANIMALS;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
GRAFT VS HOST DISEASE;
HUMANS;
MESENCHYMAL STEM CELL TRANSPLANTATION;
MESENCHYMAL STEM CELLS;
MICE;
TREATMENT FAILURE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
OSIRIS;
|
|
EID: 70449368623
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1109-966 Document Type: Note |
|
Times cited : (86)
|
|
References (0)
|
